FDA vs. CMS Mandates for Evaluating Novel MedTech

Published on: 31/05/2024

FDA approval ensures safety and effectiveness—but CMS needs proof of clinical value. Here’s how to align your strategy with both mandates.

Evidence PlanningCommercializationFundamentals
FDA vs. CMS Mandates for Evaluating Novel MedTech